New! Sign up for our free email newsletter.

Dementia News

June 25, 2025

Top Headlines

 

Our brains may work best when teetering on the edge of chaos. A new theory suggests that criticality a sweet spot between order and randomness is the secret to learning, memory, and adaptability. ...
A simple blood test could reveal which early Alzheimer’s patients are most at risk for rapid decline. Researchers found that people with high insulin resistance—measured by the TyG index—were four times more likely to experience faster ...
USC researchers have uncovered a hidden driver behind the early and severe onset of Alzheimer's in people with Down syndrome: iron overload in the brain. Their study revealed that individuals with ...
A team of scientists has discovered a direct link between the smell of food and feelings of fullness at least in lean mice. This brain circuit, located in the medial septum and triggered by food odors, helps animals eat less by making them feel ...
A new way of thinking about Alzheimer's disease has yielded a discovery that could be the key to stopping the cognitive decline seen in Alzheimer's and other neurodegenerative diseases, including ALS and ...
Researchers have released the full dataset from the Dallas Lifespan Brain Study, a decade-long project designed to track brain and cognitive health as people age and distinguish neurologically healthy paths from those indicating a likelihood of ...
Obesity is a global health problem that affects many people. In recent years, very promising anti-obesity drugs have been developed. Despite these successes, there are patients who do not respond to these drugs or suffer from side effects. ...
Humans and mice share persistent brain-activity patterns in response to adverse sensory experience, scientists find, opening a window to our emotions and, perhaps, neuropsychiatric ...
A newly refined method for measuring the Pace of Aging in population-based studies provides a powerful tool for predicting risks associated with aging, including chronic illness, cognitive ...
A new study suggests how APOE2 is protective while APOE4 increases disease risk by regulating the brain's immune ...
Worldwide, more than 55 million people suffer from dementia caused by Alzheimer's Disease (AD) and other conditions that destroy cells in the brain and nervous system. While there is no treatment to ...
Using the gene scissors CRISPR and stem cells, researchers have managed to identify a common denominator for different gene mutations that all cause the neurological disease ALS. The research shows that ALS-linked dysfunction occurs in the energy ...

Latest Headlines

updated 12:05pm EDT

Earlier Headlines

 

An increase in physical activity between the ages of 45 and 65 could help prevent Alzheimer's disease, while inactivity may be detrimental to brain ...

Prions transmit their abnormally folded shape onto other proteins. Researchers designed a synthetic fragment of the tau protein that exhibits prion-like behavior. Misfolded tau proteins are the ...

A new study found that a gene recently recognized as a biomarker for Alzheimer's disease is actually a cause of it, due to its previously unknown secondary function that triggers a pathway that ...

In a landmark clinical trial people at risk for Alzheimer's who exercised at low or moderate-high intensity showed less cognitive decline when compared to those receiving usual ...

We know exercise is good for our body, but what about our brains? A new study suggests that exercise plays a crucial role in keeping our minds sharp, even when one of the brain's key energy ...

Researchers hope to launch human clinical trials in their quest for a vaccine to prevent the buildup of pathological tau after demonstrating that this vaccine generated a robust immune response in ...

While a comprehensive cure-all to these neurological conditions is unlikely, scientists are making headway into understanding their fundamental characteristics with the hope of preventing or ...

People with Alzheimer's disease may retain their ability to empathize, despite declines in other social abilities, finds a new ...

A new study suggests that risk factors and biomarkers related to Alzheimer's disease are associated with cognition much earlier in life than previously recognized. The study highlights ...

A new way to deliver disease-fighting proteins throughout the brain may improve the treatment of Alzheimer's disease and other neurological disorders, according to scientists. By engineering ...

A new study provides solutions to the pressing need to identify factors that influence Alzheimer's disease (AD) risk or resistance while providing an avenue to explore potential biological ...

A new study has found important clues about the roles age, sex, hormonal changes and genetics play in how certain biomarkers for dementia are expressed in the blood, according to a new ...

Individuals with a genetic predisposition to Alzheimer's disease show altered blood levels indicating damaged neuronal contacts as early as 11 years before the expected onset of dementia ...

A research team has identified a previously unknown enzyme, SIRT2, that plays a key role in memory loss associated with Alzheimer's disease (AD). The study provides critical insights into how ...

Heavy drinkers who have eight or more alcoholic drinks per week have an increased risk of brain lesions called hyaline arteriolosclerosis, signs of brain injury that are associated with memory and ...

While some studies have suggested that having a mother with Alzheimer's disease may put you more at risk of developing the disease, a new study finds that having a father with the disease may be ...

Researchers have discovered a new way that neurons act in neurodegeneration by using human neural organoids -- also known as 'mini-brain' models -- from patients with frontotemporal lobar ...

Tim-3 is an immune checkpoint molecule involved in immunity and inflammation recently linked to late-onset Alzheimer's disease (AD), but its role in the brain was unknown until now. Researchers ...

Experimental drug NU-9 -- a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials for the treatment of amyotrophic lateral sclerosis (ALS) -- improves ...

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been ...

Wednesday, April 30, 2025

Monday, April 28, 2025

Friday, April 25, 2025

Thursday, April 24, 2025

Wednesday, April 23, 2025

Monday, April 21, 2025

Friday, April 18, 2025

Wednesday, April 16, 2025

Monday, April 14, 2025

Wednesday, April 9, 2025

Tuesday, April 8, 2025

Monday, April 7, 2025

Thursday, April 3, 2025

Wednesday, April 2, 2025

Monday, March 31, 2025

Wednesday, March 26, 2025

Tuesday, March 25, 2025

Monday, March 24, 2025

Friday, March 21, 2025

Wednesday, March 19, 2025

Monday, March 17, 2025

Monday, March 10, 2025

Thursday, March 6, 2025

Wednesday, March 5, 2025

Tuesday, March 4, 2025

Monday, March 3, 2025

Friday, February 28, 2025

Thursday, February 27, 2025

Wednesday, February 26, 2025

Tuesday, February 25, 2025

Monday, February 24, 2025

Thursday, February 20, 2025

Friday, February 28, 2025

Tuesday, February 18, 2025

Thursday, February 13, 2025

Tuesday, February 11, 2025

Monday, February 10, 2025

Thursday, February 6, 2025

Wednesday, February 5, 2025

Tuesday, February 4, 2025

Thursday, January 30, 2025

Wednesday, January 29, 2025

Monday, January 27, 2025

Wednesday, January 22, 2025

Tuesday, January 21, 2025

Friday, January 17, 2025

Wednesday, January 15, 2025

Monday, January 13, 2025

Wednesday, January 8, 2025

Tuesday, January 7, 2025

Thursday, January 2, 2025

Wednesday, January 1, 2025

Monday, December 23, 2024

Thursday, December 19, 2024

Wednesday, December 18, 2024

Thursday, December 12, 2024

Monday, December 9, 2024

Friday, December 6, 2024

Thursday, December 5, 2024

Wednesday, December 4, 2024

Tuesday, December 3, 2024

Monday, December 2, 2024

Wednesday, November 27, 2024